ftInvstr
SENORES · Healthcare ₹1433.0 +0.21% Mkt Cap ₹6606 Cr

SENORES

Healthcare Drug Manufacturers - General
₹1433.0
+0.21% today · 30d +7.99%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for SENORES. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹180 Cr
+30.6% YoY
NET PROFIT
₹30 Cr
+43.77% YoY
OPM
30.91%
+4.36pp YoY
EPS
₹6.61
PE 52.67
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-2.7% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
SENORES52.6715.0
GLAXO46.8657.97
RUBICON101.0127.36
PFIZER28.6424.29
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
75
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 100
Valuation STRETCHED 20
Growth STRONG 86
Profitability HIGH 85
Technicals STRONG 70
Risk LOW 90
Key Stats
TTM PE
52.67
P/B
6.37
52W HIGH
₹1599.0
OFF HIGH
-10.38%
MKT CAP
₹6606 Cr
◉ Active Signals
MACDNeutral-13.0258
RSI(14)Neutral47.9
Street Consensus
4 analysts
₹1620.0
mean target
Low ₹1500.0Now ₹1433.0High ₹1795.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SENORES and at what entry.

Sign up freeSign in